ClassID:

112949

C12Q2600/136 - page 8 - CPC Classification

Classification description:

Oligonucleotides characterized by their use Screening for pharmacological compounds

Recent Application in this class:
#2101
20100261196
2010-10-14

Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors

#2102
20100261187
2010-10-14

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

#2103
20100260738
2010-10-14

USES AND METHODS RELATING TO NDR KINASE EXPRESSION AND/OR ACTIVITY

#2104
20100257618
2010-10-07

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

#2105
20100257617
2010-10-07

Transgenic animals comprising gene fusions

#2106
20100256001
2010-10-07

BLOOD BIOMARKERS FOR MOOD DISORDERS

#2107
20100256000
2010-10-07

Genes based on thalidomide, valproic acid and methotrexate treatment for screening of drug inducing teratogenicity and screening method using thereof

#2108
20100255475
2010-10-07

DIAGNOSTICS AND THERAPEUTICS FOR OSTEOPOROSIS

#2109
20100255471
2010-10-07

Single cell gene expression for diagnosis, prognosis and identification of drug targets

#2110
20100255470
2010-10-07

Gene Expression Profiling for Identification, Monitoring and Treatment of Breast Cancer

#2111
20100249213
2010-09-30

MicroRNA Signatures in Human Ovarian Cancer

#2112
20100249209
2010-09-30

GENE INVOLVED IN IMMORTALIZATION OF HUMAN CANCER CELL AND USE THEREOF

#2113
20100248241
2010-09-30

MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571

#2114
20100248230
2010-09-30

NOVEL MEDICAL DIAGNOSTIC METHOD AND THERAPY IN THE CONTEXT OF INTERFREON-STIMULATED GENES THAT INDUCE DEPRESSION

#2115
20100248225
2010-09-30

GENE EXPRESSION PROFILING FOR IDENTIFICATION, MONITORING AND TREATMENT OF MELANOMA

#2116
20100242127
2010-09-23

METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION

#2117
20100240574
2010-09-23

HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor

#2118
20100240057
2010-09-23

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA

#2119
20100240034
2010-09-23

Gene defects and mutant ALK kinase in human solid tumors

#2120
20100239656
2010-09-23

EGFR/NEDD9/TGF-BETA INTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

#2121
20100239592
2010-09-23

METHODS OF ANALYSIS AND DETECTING MOLECULAR DEFECTS IN TRANSCOBALAMIN I DEFICIENCY

#2122
20100239581
2010-09-23

Detection of CXADR protein for diagnosis of kidney cancer

#2123
20100239566
2010-09-23

Enigma-Mdm2 interaction and uses thereof

#2124
20100239501
2010-09-23

GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF

#2125
20100234445
2010-09-16

Patterns of known and novel small RNAS in human cervical cancer

#2126
20100233718
2010-09-16

NON-INVASIVE TECHNIQUE FOR CONDUCTING SKIN INFLAMMATORY DISEASE PHARMACO-GENOMIC STUDIES AND DIAGNOSES THEREOF

#2127
20100233716
2010-09-16

TRANSPLANT REJECTION MARKERS

#2128
20100233702
2010-09-16

METHOD TO PREDICT RESPONSE TO TREATMENT FOR PSYCHIATRIC ILLNESSES

#2129
20100233691
2010-09-16

Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate Cancer

#2130
20100233684
2010-09-16

Method for determining inflammatory disease

#2131
20100233680
2010-09-16

Gene Expression Profiles and Methods of Use

#2132
20100233187
2010-09-16

Gene products differentially expressed in cancerous cells

#2133
20100233171
2010-09-16

Differential Drug Sensitivity

#2134
20100227909
2010-09-09

Compositions comprising MIR34 therapeutic agents for treating cancer

#2135
20100227838
2010-09-09

Combination therapy for treating cancer and diagnostic assays for use therein

#2136
20100227778
2010-09-09

Diagnosis and Treatment of Noonan Syndrome and Neoplastic Disorders

#2137
20100226858
2010-09-09

Method of predicting a predisposition to QT prolongation

#2138
20100222228
2010-09-02

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING IRRITABLE BOWEL SYNDROME

#2139
20100221754
2010-09-02

Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators

#2140
20100221753
2010-09-02

Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms

#2141
20100221737
2010-09-02

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#2142
20100221733
2010-09-02

BIOMARKER OF ALLERGIC DISEASE AND USE OF THE SAME

#2143
20100221731
2010-09-02

Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression

#2144
20100221730
2010-09-02

Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer

#2145
20100221729
2010-09-02

Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer

#2146
20100221249
2010-09-02

WISP POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME

#2147
20100218266
2010-08-26

METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS

#2148
20100216863
2010-08-26

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

#2149
20100216713
2010-08-26

NOVEL COMPOSITIONS AND METHODS IN CANCER ASSOCIATED WITH ALTERED EXPRESSION OF PRLR

#2150
20100216664
2010-08-26

Method

#2151
20100216653
2010-08-26

USE OF POLYMORPHISMS IN THE TMEM132D GENE IN THE PREDICTION AND TREATMENT OF ANXIETY DISORDERS

#2152
20100216154
2010-08-26

Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof

#2153
20100216140
2010-08-26

Human Dickkopf-related protein and nucleic acid molecules and uses therefor

#2154
20100216137
2010-08-26

Gene Expression Profiling for Identification, Monitoring and Treatment of Ovarian Cancer

#2155
20100216130
2010-08-26

SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS

#2156
20100215678
2010-08-26

Ras mutation and compositions and methods related thereto

#2157
20100215665
2010-08-26

Mixed lineage kinases and metabolic disorders

#2158
20100215638
2010-08-26

METHOD FOR TREATMENT OF PROSTATE CANCER AND SCREENING OF PATIENTS BENEFITING FROM SAID METHOD

#2159
20100210545
2010-08-19

PREVENTIVE/REMEDY FOR CANCER

#2160
20100209931
2010-08-19

Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same

#2161
20100209929
2010-08-19

MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY

#2162
20100209924
2010-08-19

Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization

#2163
20100209915
2010-08-19

Gene Expression Profiling for Identification, Monitoring, and Treatment of Ocular Disease

#2164
20100209906
2010-08-19

Methods and compositions for detecting colon cancers

#2165
20100204311
2010-08-12

Normal-tension glaucoma model and method for evaluation of test substances by using same

#2166
20100204060
2010-08-12

Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma

#2167
20100204058
2010-08-12

Profiling for Determination of Response to Treatment for Inflammatory Disease

#2168
20100203503
2010-08-12

GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION AND USES THEREOF

#2169
20100203063
2010-08-12

Pestivirus species

#2170
20100202973
2010-08-12

MICRORNA MOLECULES ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS

#2171
20100197518
2010-08-05

Methods for Diagnosing Ischemia

#2172
20100196891
2010-08-05

IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer

#2173
20100196889
2010-08-05

Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer

#2174
20100196509
2010-08-05

Methods for Diagnosis and Treatment of Endometrial Cancer

#2175
20100196366
2010-08-05

Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto

#2176
20100190685
2010-07-29

PROGNOSTIC FACTOR IN SARCOMA, AND METASTASIS INHIBITOR

#2177
20100190650
2010-07-29

TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS

#2178
20100190264
2010-07-29

Genetic variants increase the risk of age-related macular degeneration

#2179
20100190176
2010-07-29

TUMOR SUPPRESSOR DESIGNATED TS10Q23.3

#2180
20100190172
2010-07-29

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

#2181
20100189695
2010-07-29

IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS

#2182
20100184843
2010-07-22

IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER

#2183
20100184842
2010-07-22

Ultraconserved regions encoding ncRNAs

#2184
20100184658
2010-07-22

Methods for treatment of type 1 diabetes

#2185
20100184624
2010-07-22

ARRAYS AND METHODS COMPRISING M. SMITHII GENE PRODUCTS

#2186
20100184100
2010-07-22

Tyrosine kinome

#2187
20100184077
2010-07-22

Allelic Form of the HMGA2 Gene Predisposing Women to the Formation of Leiomyomas

#2188
20100184058
2010-07-22

PERIPHERICAL TISSUE SAMPLE CONTAINING CELLS EXPRESSING THE 5HTR2C AND/OR ADARS AS MARKERS OF THE ALTERATION OF THE MECHANISM OF THE 5HTR2C MRNA EDITING AND ITS APPLICATIONS

#2189
20100184034
2010-07-22

Gene Expression Profiling for Identification, Monitoring and Treatment of Lung Cancer

#2190
20100183520
2010-07-22

Netrin-1 as a biomarker of injury and disease

#2191
20100179163
2010-07-15

NOL3 is a predictor of patient outcome

#2192
20100178651
2010-07-15

Bifunctional Predictors of Cancer Treatment Sensitivity and Resistance

#2193
20100173975
2010-07-08

Expressed pseudogene regulates gene expression

#2194
20100173317
2010-07-08

KIF11 and method for diagnosing non-small cell lung cancer

#2195
20100172908
2010-07-08

METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1

#2196
20100172838
2010-07-08

Endometrial biomarkers

#2197
20100168067
2010-07-01

BIOMARKERS FOR BISPHOSPHONATE-RESPONSIVE BONE DISORDERS

#2198
20100168016
2010-07-01

DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS

#2199
20100167286
2010-07-01

Pluripotent cell lines and methods of use thereof

#2200
20100167285
2010-07-01

METHODS AND AGENTS FOR EVALUATING INFLAMMATORY BOWEL DISEASE, AND TARGETS FOR TREATMENT

#2201
20100166797
2010-07-01

Gammaretrovirus associated with cancer

#2202
20100162422
2010-06-24

Novel therapeutic and diagnostic products and methods

#2203
20100162420
2010-06-24

Gastric carcinoma gene ZNF312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same

#2204
20100160171
2010-06-24

Methods For Detection Of Sepsis

#2205
20100154071
2010-06-17

FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER

#2206
20100152058
2010-06-17

Cancer markers

#2207
20100151588
2010-06-17

MEANS AND METHODS FOR DIAGNOSING AND TREATING CANCER BASED ON THE FRMD3 GENE

#2208
20100151466
2010-06-17

DIAGNOSIS AND TREATMENT OF CERVICAL CANCER

#2209
20100151457
2010-06-17

Detection of Unhealthy Cell and Uses Thereof

#2210
20100151453
2010-06-17

DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia

#2211
20100146642
2010-06-10

Methods using PBK1 for identifying agents that treat metabolic disorders

#2212
20100144850
2010-06-10

Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis

#2213
20100144830
2010-06-10

CANCER CELL IDENTIFICATION MARKER AND CANCER CELL PROLIFERATION INHIBITOR

#2214
20100144673
2010-06-10

Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling

#2215
20100144555
2010-06-10

QUALITATIVE DIFFERENTIAL SCREENING

#2216
20100143948
2010-06-10

Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics

#2217
20100143946
2010-06-10

Alpha-synuclein kinase

#2218
20100143918
2010-06-10

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#2219
20100143899
2010-06-10

METHODS AND PRODUCTS FOR DIAGNOSING CANCER

#2220
20100143386
2010-06-10

FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs

#2221
20100143379
2010-06-10

MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF

#2222
20100143373
2010-06-10

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#2223
20100143372
2010-06-10

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#2224
20100143337
2010-06-10

Compositions and methods for characterizing and regulating olfactory sensation

#2225
20100137164
2010-06-03

Biomarkers for predicting prostate cancer progression

#2226
20100136541
2010-06-03

IDENTIFICATION AND VERIFICATION OF METHYLATION MARKER SEQUENCES

#2227
20100130586
2010-05-27

Diagnosis and treatment of T-cell acute lymphoblastic leukemia

#2228
20100129824
2010-05-27

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

#2229
20100129804
2010-05-27

SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF

#2230
20100129790
2010-05-27

Method for Determining Phospholipidosis

#2231
20100124747
2010-05-20

COMPOSITIONS AND METHODS FOR DIAGNOSIS OR PROGNOSIS OF TESTICULAR CANCER

#2232
20100120898
2010-05-13

MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

#2233
20100120788
2010-05-13

IDENTIFICATION OF POLYNUCLEOTIDES FOR PREDICTING ACTIVITY OF COMPOUNDS THAT INTERACT WITH AND/OR MODULATE PROTEIN TYROSINE KINASES AND/OR PROTEIN TYROSINE KINASE PATHWAYS IN PROSTATE CELLS

#2234
20100120050
2010-05-13

Biomarkers For Assessing Altherosclerotic Potential

#2235
20100120049
2010-05-13

BIOMARKERS FOR SERIOUS SKIN RASH

#2236
20100120045
2010-05-13

GENETIC VARIANTS USEFUL FOR RISK ASSESSMENTS OF CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION

#2237
20100120041
2010-05-13

METHODS FOR DETECTING AND TREATING KIDNEY DISEASE

#2238
20100120040
2010-05-13

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

#2239
20100120025
2010-05-13

Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of Cancers

#2240
20100119513
2010-05-13

Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

#2241
20100113561
2010-05-06

Microrna molecules

#2242
20100113470
2010-05-06

BCR-ABL variants

#2243
20100112603
2010-05-06

METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT

#2244
20100112587
2010-05-06

TRANSCRIPTOMIC BIOMARKERS FOR INDIVIDUAL RISK ASSESSMENT IN NEW ONSET HEART FAILURE

#2245
20100112566
2010-05-06

VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use

#2246
20100111991
2010-05-06

Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer

#2247
20100111956
2010-05-06

Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer

#2248
20100111874
2010-05-06

METHOD OF CANCER DETECTION AND TREATMENT

#2249
20100105564
2010-04-29

Stroma Derived Predictor of Breast Cancer

#2250
20100105064
2010-04-29

METHOD OF SCREENING TEST SUBSTANCES FOR TREATING OR PREVENTING A DISEASE MEDIATED BY PLASMA CELLS

#2251
20100105045
2010-04-29

DNP63A gene and screening methods of anticancer agent by using it

#2252
20100105034
2010-04-29

Detecting and treating dementia

#2253
20100104581
2010-04-29

Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions

#2254
20100104579
2010-04-29

TREX1 AS A MARKER FOR LUPUS ERYTHEMATOSUS

#2255
20100100979
2010-04-22

Biomarker specific for cancer

#2256
20100099748
2010-04-22

MicroRNA molecules

#2257
20100099116
2010-04-22

Methods for Analysis of Hedgehog Pathway Inhibitors

#2258
20100099107
2010-04-22

METHOD FOR IDENTIFYING AN INTESTINAL PHENOTYPE

#2259
20100099101
2010-04-22

METHODS FOR TREATING, DIAGNOSING, AND MONITORING LUPUS

#2260
20100099083
2010-04-22

CROHN DISEASE SUSCEPTIBILITY GENE

#2261
20100098625
2010-04-22

ICBP90 POLYPEPTIDE AND ITS FRAGMENTS AND POLYNUCLEOTIDES CODING FOR SAID POLYPEPTIDES AND APPLICATIONS FOR DIAGNOSING AND TREATING CANCER

#2262
20100093837
2010-04-15

MicroRNA molecules

#2263
20100093768
2010-04-15

Agents for reversing epigenetic silencing of genes

#2264
20100093629
2010-04-15

Genes and polypeptides relating to human pancreatic cancers

#2265
20100093552
2010-04-15

USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES

#2266
20100088778
2010-04-08

Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene

#2267
20100087514
2010-04-08

METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS

#2268
20100087513
2010-04-08

Microrna molecules

#2269
20100087512
2010-04-08

MicroRNA molecules

#2270
20100087328
2010-04-08

BRM EXPRESSION AND RELATED DIAGNOSTICS

#2271
20100086940
2010-04-08

Method for detecting endometriosis in a patient sample

#2272
20100086922
2010-04-08

Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment

#2273
20100086921
2010-04-08

GENETIC SUSCEPTIBILITY VARIANTS OF TYPE 2 DIABETES MELLITUS

#2274
20100081648
2010-04-01

Methods for characterizing and treating cognitive impairment in aging and disease

#2275
20100081153
2010-04-01

CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES

#2276
20100081136
2010-04-01

CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

#2277
20100077496
2010-03-25

MO-1, A Gene Associated With Morbid Obesity

#2278
20100076059
2010-03-25

METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10

#2279
20100075365
2010-03-25

Perinucleolar compartment as a cancer marker

#2280
20100075325
2010-03-25

COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER

#2281
20100075308
2010-03-25

POLYMORPHISMS IN GENES AFFECTING CNS DISORDERS AND USES THEREOF

#2282
20100068715
2010-03-18

MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE PRODUCTION

#2283
20100068705
2010-03-18

Genetic susceptibility variants associated with cardiovascular disease

#2284
20100068207
2010-03-18

DDR2 in Cancer Diagnosis, Detection and Treatment

#2285
20100062443
2010-03-11

Methods for the diagnosis and treatment of lung cancer

#2286
20100062002
2010-03-11

Brain Endothelial Cell Expression Patterns

#2287
20100061977
2010-03-11

Methods and compositions for treating and diagnosing diseases

#2288
20100056611
2010-03-04

MN/CA9 Splice Variants

#2289
20100056608
2010-03-04

METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2

#2290
20100056445
2010-03-04

ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA

#2291
20100055704
2010-03-04

Expression profile of thyroid cancer

#2292
20100055694
2010-03-04

Molecular signature representative of dysfunctions in epidermal homeostasis

#2293
20100055688
2010-03-04

SLIT2 underexpression in metastatic prostate cancer

#2294
20100055687
2010-03-04

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571

#2295
20100055686
2010-03-04

Methods for diagnosis of common acute lymphoblastic leukemia by determining the level of gene expression

#2296
20100048674
2010-02-25

Role of miRNA in T cell leukemia

#2297
20100048414
2010-02-25

Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation

#2298
20100047868
2010-02-25

Tumour Suppressor Protein

#2299
20100047810
2010-02-25

Compositions and methods for treating diseases associated with T-box and N-Myc

#2300
20100047809
2010-02-25

PCA3, PCA3 genes, and methods of use

#2301
20100047807
2010-02-25

GENETIC VARIANTS ASSOCIATED WITH PERIODIC LIMB MOVEMENTS AND RESTLESS LEGS SYNDROME

#2302
20100047787
2010-02-25

PROSTATE CANCER SURVIVAL AND RECURRENCE

#2303
20100047784
2010-02-25

Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid

#2304
20100047783
2010-02-25

SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALING

#2305
20100047782
2010-02-25

Assessment of risk for colorectal cancer

#2306
20100047777
2010-02-25

METHODS FOR IDENTIFYING MUTATIONS IN CODING AND NON-CODING DNA

#2307
20100047776
2010-02-25

Cell-based screening assays for compounds that regulate the expresion of a tumor marker dj-1

#2308
20100047240
2010-02-25

Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors

#2309
20100041617
2010-02-18

Modulating mxa expression

#2310
20100041564
2010-02-18

METHOD FOR ESTABLISHING THE SOURCE OF INFECTION IN A CASE OF FEVER OF UNCLEAR AETIOLOGY

#2311
20100041048
2010-02-18

Circulating Mutant DNA to Assess Tumor Dynamics

#2312
20100041032
2010-02-18

COMPOSITION AND METHODS FOR THE DETECTION OF CRIPTO-3

#2313
20100035983
2010-02-11

Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof

#2314
20100035758
2010-02-11

Method for detecting oral squamous-cell carcinoma

#2315
20100035265
2010-02-11

Biomarkers for Drug-Induced Liver Injury

#2316
20100034821
2010-02-11

GENETIC VARIATIONS ASSOCIATED WITH TUMORS

#2317
20100034736
2010-02-11

IDENTIFICATION OF CANCER STEM CELLS USING GENETIC MARKERS

#2318
20100029748
2010-02-04

Metastasis Promoting Genes and Proteins

#2319
20100029702
2010-02-04

Method For Identification of Compound Having Anti-Anxiety Effect

#2320
20100029676
2010-02-04

T315A AND F317I MUTATIONS OF BCR-ABL KINASE DOMAIN

#2321
20100028882
2010-02-04

METHODS FOR DIAGNOSING OSTEOARTHRITIS

#2322
20100028264
2010-02-04

LTBP2 as a biomarker and diagnostic target

#2323
20100022639
2010-01-28

Methods of Inducing Weight Loss

#2324
20100022624
2010-01-28

Methods of treating smooth muscle cell disorders

#2325
20100022440
2010-01-28

VH4 codon signature for multiple sclerosis

#2326
20100021913
2010-01-28

Stimulus-elicited genomic profile markers of alzheimer's disease

#2327
20100021898
2010-01-28

MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF

#2328
20100021889
2010-01-28

Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia

#2329
20100017901
2010-01-21

Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use

#2330
20100017897
2010-01-21

PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis

#2331
20100016938
2010-01-21

Diagnosing, monitoring and treating inflammation

#2332
20100015625
2010-01-21

CTIP2 expression in squamous cell carcinoma

#2333
20100015620
2010-01-21

CANCER-LINKED GENES AS BIOMARKERS TO MONITOR RESPONSE TO IMPDH INHIBITORS

#2334
20100015605
2010-01-21

Method of hepatocellular carcinoma classification and prognosis

#2335
20100015152
2010-01-21

Diagnostic and therapeutic methods

#2336
20100015129
2010-01-21

Methods of using F-spondin as a biomarker for cartilage degenerative conditions and bone diseases

#2337
20100010073
2010-01-14

MicroRNA (miRNA) for the diagnosis and treatment of heart diseases

#2338
20100009920
2010-01-14

TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER

#2339
20100009382
2010-01-14

Methods and compositions for diagnosing prostate cancer

#2340
20100009368
2010-01-14

METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF CARDIOVASCULAR FUNCTION AND DISORDERS

#2341
20100009363
2010-01-14

RBP4 in insulin sensitivity/resistance, diabetes, and obesity

#2342
20100009361
2010-01-14

Compositions and methods for detecting Noonan syndrome

#2343
20100009359
2010-01-14

Methods and compositions for detecting colon cancers

#2344
20100009358
2010-01-14

Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

#2345
20100008935
2010-01-14

METHOD FOR IDENTIFYING THERAPEUTICAL TARGETS IN TUMORS, THE USE THEREOF AND MEANS FOR DETERMINING AND TARGETING ANGIOGENESIS AND HEMOSTASIS RELATED TO ANDENOCARCINOMAS OF THE LUNG

#2346
20100008934
2010-01-14

GENETIC POLYMORPHISMS ASSOCIATED WITH AUTOINFLAMMATORY DISEASES, METHODS OF DETECTION AND USES THEREOF

#2347
20100004161
2010-01-07

Toll like receptor 4 dysfunction and the biological applications thereof

#2348
20100003689
2010-01-07

Use of Methylation Status of MINT Loci as a Marker for Rectal Cancer

#2349
20100003682
2010-01-07

Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

#2350
20100003670
2010-01-07

CHARACTERIZING PROSTATE CANCER

#2351
20100003257
2010-01-07

Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion

#2352
20100003241
2010-01-07

Agents for treatment or prevention of an allergic disorder

#2353
20090325176
2009-12-31

Gene Expression Profiles Associated with Asthma Exacerbation Attacks

#2354
20090325163
2009-12-31

Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke

#2355
20090325150
2009-12-31

KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK

#2356
20090324618
2009-12-31

NOVEL SIGNATURE SELF RENEWAL GENE EXPRESSION PROGRAMS

#2357
20090324610
2009-12-31

GENE ASSOCIATED WITH ARTERIOSCLEROTIC DISEASE, AND USE THEREOF

#2358
20090324608
2009-12-31

Novel human protein kinase, phosphatase, and protease family members and uses thereof

#2359
20090324583
2009-12-31

Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation

#2360
20090318672
2009-12-24

Antibodies to PRO352

#2361
20090318535
2009-12-24

β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis

#2362
20090317816
2009-12-24

METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF

#2363
20090317392
2009-12-24

METHOD OF DIAGNOSING SMALL CELL LUNG CANCER

#2364
20090317391
2009-12-24

Cancer Related Genes (PTPE)

#2365
20090312410
2009-12-17

Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof

#2366
20090312298
2009-12-17

Methods and compositions related to GABA receptor subunits

#2367
20090311695
2009-12-17

Method

#2368
20090311685
2009-12-17

NMU-GHSR1b/NTSR1 oncogenic signaling pathway as a therapeutic target for lung cancer

#2369
20090311261
2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#2370
20090311260
2009-12-17

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#2371
20090311256
2009-12-17

12 human secreted proteins

#2372
20090305972
2009-12-10

Cancer-associated antigen

#2373
20090305903
2009-12-10

METHODS AND COMPOSITIONS FOR DIAGNOSIS, MONITORING AND DEVELOPMENT OF THERAPEUTICS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

#2374
20090305289
2009-12-10

SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES

#2375
20090305242
2009-12-10

Skin aging marker and technique for use thereof

#2376
20090304728
2009-12-10

TEM8 GENE, EXPRESSION FORMS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#2377
20090304705
2009-12-10

Biomarkers for chronic transplant dysfunction

#2378
20090304704
2009-12-10

METHODS FOR DIAGNOSING AND PREDICTING NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#2379
20090304680
2009-12-10

DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE

#2380
20090304653
2009-12-10

METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS

#2381
20090298873
2009-12-03

Methods of screening for compounds that reduce microbial resistance to fluoroquinolones

#2382
20090298766
2009-12-03

DETECTION AND TREATMENT OF CANCERS

#2383
20090298763
2009-12-03

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

#2384
20090298071
2009-12-03

METHOD FOR TESTING DRUG SENSITIVITY IN SOLID TUMORS BY QUANTIFYING MRNA EXPRESSION IN THINLY-SLICED TUMOR TISSUE

#2385
20090298061
2009-12-03

Diagnostic Methods for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapy

#2386
20090297563
2009-12-03

Diagnosis And Treatment of Immune-Related Diseases

#2387
20090297536
2009-12-03

Compositions, kits, and methods for identification, assessment, prevention and treatment of pancreatic adenocarcinoma in humans

#2388
20090297525
2009-12-03

Compositions, kits and methods for identification, assessment, prevention and therapy of cancer

#2389
20090292009
2009-11-26

MODULATION OF STAT 6 EXPRESSION

#2390
20090291432
2009-11-26

Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene

#2391
20090291047
2009-11-26

Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer

#2392
20090288176
2009-11-19

Novel Gene Disruptions, Compositions and Methods Relating Thereto

#2393
20090286856
2009-11-19

Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide

#2394
20090286849
2009-11-19

Modulation of insulin like growth factor I receptor expression

#2395
20090286255
2009-11-19

Methods for assessing efficacy of chemotherapeutic agents

#2396
20090286242
2009-11-19

MicroRNA Expression Profiling and Uses Thereof

#2397
20090285796
2009-11-19

MUTANT JAK3 KINASE IN HUMAN LEUKEMIA

#2398
20090282496
2009-11-12

Androgen Receptor Related Methods for Treating Bladder Cancer

#2399
20090280479
2009-11-12

USE OF FREE CIRCULATING DNA FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER FUNDING

#2400
20090275608
2009-11-05

Methods of diagnosing and treating parp-mediated diseases